New research from Sweden has found that GLP-one agonist drugs utilised to deal with diabetic issues and obesity are not likely to improve thyroid cancer risk, as some…This is exactly why pharmacotherapy and bariatric and metabolic surgery treatment plans are needed — to counteract these intrinsic weight-advertising mechanisms,” he extra.Thank